Navigation Links
Well-known author and historian reports on progress in Huntington's therapies
Date:6/25/2012

Amsterdam, NL, June 25, 2012 Our understanding of the causes and mechanisms of Huntington's disease (HD) has grown at a dramatic pace since the discovery of the genetic marker for the disease in 1983. While therapies to treat the disease lag behind these laboratory discoveries, disease altering interventions are moving closer to the clinic. In the inaugural issue of the Journal of Huntington's Disease Alice Wexler, PhD, an authority on the history of Huntington's disease, author, and research scholar with the UCLA Center for the Study of Women, recounts important milestones along the journey towards a treatment or cure for the disease.

"When the abnormal gene that causes HD was identified in 1993, many of us in HD families imagined that a cure or at least an effective treatment was close at hand," says Dr. Wexler. "That dream has not yet been realized. But if the history of HD can provide clues for the future, it suggests that change doesn't always happen gradually. It can also happen swiftly. And that, I believe, is a great source for hope."

Although clinical accounts of HD date back to the mid-19th century, as late as the 1960s few doctors knew anything about it. Those who did could offer no effective treatments and families with the illness tried hard to keep it hidden. "All of a sudden, in the 1960s, this began to change," says Dr. Wexler. Grassroots advocacy by HD families, and the efforts of a small international network of neurologists who formed international collaborations to study the disease, began to have an impact.

The genetic marker for HD was discovered in 1983, and HD research intensified. It reached a dramatic turning point in 1993, when the discovery of the genetic abnormality that causes HD made possible an array of new models and experimental approaches. Since then, scientists have created a variety of new animal and cell models, identified potential genetic modifiers, and illuminated many aspects of neuronal dysfunction. They are also testing methods of gene silencing and other novel therapeutic strategies in a variety of animal models.

"For families struggling daily with HD, effective intervention can't come soon enough," says Dr. Wexler. "But the volume of research has increased tremendously in the past decade. Disease altering interventions are moving closer to the clinic. The launch of the Journal of Huntington's Disease provides a welcome new resource in our campaign to heal a formidable disease."


'/>"/>

Contact: Daphne Watrin
d.watrin@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

Related medicine news :

1. Preventing Oral Diseases Begins in Pregnancy Claims Author in New eBook
2. Dr. Carol Francis Radio Talk Show Discusses Sexual Abuse as Related to "Coach" Jerry Sandusky; Interview With Abuse Survivor Teresa Joyce, Author of "There's A Fine Line"
3. Dana-Farber: Study reports first success of targeted therapy in type of non-small cell lung cancer
4. Reactions to HIV drug have autoimmune cause, reports AIDS journal
5. Study examines necessity of additional imaging in PET/CT oncologic reports
6. 1 in 3 households misreports smoke alarm coverage
7. Mount Sinai researcher finds timing of ADHD medication affect academic progress
8. San Diego Physician to be Recognized at White House for Progress in Health IT
9. No Progress in Reducing U.S. Motorcycle Deaths: Report
10. Biosynthetic grape-derived compound prevents progression of Alzheimers disease in mice
11. RANK protein promotes the initiation, progression and metastasis of human breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: